Work

A phase II study of cisplatin (P) plus etoposide (E) plus bevacizumab (B) for previously untreated extensive stage small cell lung cancer (SCLC) (E3501): A trial of the Eastern Cooperative Oncology Group

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.7564

Authors: A. Sandler, S. Szwaric, A. Dowlati, D. F. Moore, J. H. Schiller

Institutions: Vanderbilt University, University Hospitals of Cleveland, Dana-Farber Cancer Institute, Vanderbilt-Ingram Cancer Center, The University of Texas Southwestern Medical Center

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2242249772

Cites:

Cited by: 38

Related to: 10